Novogene Co., Ltd.
Status: Publicly traded
Direct answer
Novogene Co., Ltd. is publicly traded on SHH under the ticker 688315.SS.
Novogene Co., Ltd. is a global provider of comprehensive genomic services and advanced solutions. Its offerings span a wide array of genomic applications, including human, animal, plant, and microbial genome sequencing, alongside gene regulation and single-cell sequencing technologies. The company also specializes in cancer genomic profiling, whole exome sequencing (including clinical-grade versions), and FFPE RNA...
Can you invest in Novogene Co., Ltd.?
Yes. Novogene Co., Ltd. trades publicly on SHH as 688315.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Novogene Co., Ltd.
Detailed equity research is provided by MarketSnap.